Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Ottobock, a German company founded in 1919 and headquartered in Duderstadt, specializes in the development and production of exoskeletons for the technology and healthcare sectors. The company's primary focus is on creating innovative exoskeleton solutions designed to assist workers in physically demanding jobs, particularly in industries such as logistics, automotive, and mobility.
As a family-owned business held by Näder Holding GmbH & Co. KG, Ottobock has a rich history spanning over a century. The company's exoskeletons are engineered to provide support and reduce strain during tasks like lifting heavy loads or working at shoulder height, addressing the need for improved ergonomics and worker safety in various industrial settings.
While Ottobock has established itself as a leader in the exoskeleton market, there is currently no public information available regarding the company's IPO prospects. As a privately held company, Ottobock's financial details and future plans for going public remain undisclosed. Potential investors interested in Ottobock stock or shares should be aware that the company is not currently traded on public markets.
It's important to note that any discussions about Ottobock's potential IPO or the possibility to invest in Ottobock stock are purely speculative at this time. The company's status as a family-owned business may influence its decision-making process regarding any future public offerings. As with any private company, the decision to go public would depend on various factors, including market conditions, growth strategies, and the company's long-term objectives.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Ottobock's IPO prospects remain uncertain, investors eager to gain exposure to the innovative prosthetics and orthotics industry don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, potentially allowing you to benefit from the growth of healthcare technology leaders before they go public. Our platform provides the opportunity to diversify your portfolio with lower minimum investments in promising companies like Ottobock, making it easier for accredited investors to participate in the future of medical technology.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
